COMPARATIVE AND COMBINED EFFECTS OF INTERLEUKIN-6, INTERLEUKIN-1-BETA, AND TUMOR-NECROSIS-FACTOR-ALPHA ON PROTEOGLYCAN METABOLISM OF HUMAN ARTICULAR CHONDROCYTES CULTURED IN AGAROSE
Am. Malfait et al., COMPARATIVE AND COMBINED EFFECTS OF INTERLEUKIN-6, INTERLEUKIN-1-BETA, AND TUMOR-NECROSIS-FACTOR-ALPHA ON PROTEOGLYCAN METABOLISM OF HUMAN ARTICULAR CHONDROCYTES CULTURED IN AGAROSE, Journal of rheumatology, 21(2), 1994, pp. 314-320
Objective. To study the effects of recombinant tumor necrosis factor a
lpha (TNF-alpha), interleukin 1 beta (IL-1 beta) and interleukin 6 (IL
-6) on proteoglycan metabolism of isolated chondrocytes. Methods. Huma
n articular cartilage cells were cultured in agarose gel. In these cul
ture conditions, chondrocytes keep their phenotypic stability. They re
lease cartilage specific proteoglycans into the surrounding artificial
matrix. Proteoglycan synthesis was measured by the incorporation of (
35)sulfate (S-35). Results. TNF-alpha and IL-1 beta depressed proteogl
ycan synthesis and induced proteoglycan degradation. The effects of bo
th cytokines were additive, when used in submaximal doses. No mutual i
nduction of TNF-alpha and IL-1 beta was shown, but both cytokines stim
ulated the chondrocytes to release IL-6, up to 100,000 pg/ml. Equal am
ounts of human recombinant IL-6 did not affect proteoglycan synthesis.
IL-6 did not alter proteoglycan quality, nor did it modulate the IL-1
beta activities on proteoglycan metabolism. Conclusion. These finding
s illustrate the role of IL-1 beta and TNF-alpha in cartilage degradat
ion and suggest that the role of the large amounts of IL-6 released in
response to IL-1 in chronic arthritis is not directly protective with
regard to proteoglycan metabolism.